报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 10.9% | 7.6% | 205.32% | 6/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
2024-06-30 | 3.57% | -47.5% | 95.08% | 12/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
2024-03-31 | 1.83% | -43.52% | -86.08% | 13/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
2023-12-31 | 13.15% | -2.45% | 29.81% | 7/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
2023-09-30 | 10.13% | 9.16% | 48.97% | 12/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
2023-06-30 | 6.8% | 3.03% | 109.88% | 12/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
2023-03-31 | 3.24% | 31.71% | -75.96% | 12/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
2022-12-31 | 13.48% | -3.58% | 45.26% | 15/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
2022-09-30 | 9.28% | -16.99% | 40.61% | 20/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
2022-06-30 | 6.6% | 2.96% | 168.29% | 16/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
2022-03-31 | 2.46% | -9.89% | -82.4% | 21/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
2021-12-31 | 13.98% | 44.87% | 25.04% | 19/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
2021-09-30 | 11.18% | 15.62% | 74.41% | 17/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
2021-06-30 | 6.41% | 41.5% | 134.8% | 20/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
2021-03-31 | 2.73% | 110% | -71.71% | 16/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
2020-12-31 | 9.65% | -37.42% | -0.21% | 30/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
2020-09-30 | 9.67% | -16.78% | 113.47% | 15/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
2020-06-30 | 4.53% | -20.11% | 248.46% | 16/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
2020-03-31 | 1.3% | -36.89% | -91.57% | 14/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
2019-12-31 | 15.42% | 2.46% | 32.7% | 20/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
2019-09-30 | 11.62% | 7.49% | 104.94% | 12/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
2019-06-30 | 5.67% | -4.06% | 175.24% | 12/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
2019-03-31 | 2.06% | 2% | -86.31% | 13/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
2018-12-31 | 15.05% | 29.41% | 39.22% | 15/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
2018-09-30 | 10.81% | 2% | 82.91% | 10/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
2018-06-30 | 5.91% | 2% | -49.18% | 11/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
2017-12-31 | 11.63% | -39.58% | -39.58% | 16/51 | 1.73% | 普蕊斯 | 22.99% | 行业排名> |
2016-12-31 | 19.25% | 2% | 2% | 9/51 | 23.06% | 通策医疗 | 6.02% | 行业排名> |